These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

679 related articles for article (PubMed ID: 17349045)

  • 21. Change in mutation patterns of Plasmodium vivax dihydrofolate reductase (Pvdhfr) and dihydropteroate synthase (Pvdhps) in P. vivax isolates from malaria endemic areas of Thailand.
    Kuesap J; Rungsrihirunrat K; Thongdee P; Ruangweerayut R; Na-Bangchang K
    Mem Inst Oswaldo Cruz; 2011 Aug; 106 Suppl 1():130-3. PubMed ID: 21881767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antifolates can have a role in the treatment of Plasmodium vivax.
    Hawkins VN; Joshi H; Rungsihirunrat K; Na-Bangchang K; Sibley CH
    Trends Parasitol; 2007 May; 23(5):213-22. PubMed ID: 17368986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of molecular markers of anti-malarial drug resistance in Plasmodium vivax and Plasmodium falciparum in two districts of Nepal.
    Ranjitkar S; Schousboe ML; Thomsen TT; Adhikari M; Kapel CM; Bygbjerg IC; Alifrangis M
    Malar J; 2011 Apr; 10():75. PubMed ID: 21457533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular markers of in vivo Plasmodium vivax resistance to amodiaquine plus sulfadoxine-pyrimethamine: mutations in pvdhfr and pvmdr1.
    Marfurt J; de Monbrison F; Brega S; Barbollat L; Müller I; Sie A; Goroti M; Reeder JC; Beck HP; Picot S; Genton B
    J Infect Dis; 2008 Aug; 198(3):409-17. PubMed ID: 18582193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Geographical distribution of amino acid mutations in Plasmodium vivax DHFR and DHPS from malaria endemic areas of Thailand.
    Rungsihirunrat K; Sibley CH; Mungthin M; Na-Bangchang K
    Am J Trop Med Hyg; 2008 Mar; 78(3):462-7. PubMed ID: 18337344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic efficacy of sulfadoxine-pyrimethamine and prevalence of resistance markers in Tanzania prior to revision of malaria treatment policy: Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase mutations in monitoring in vivo resistance.
    Mugittu K; Ndejembi M; Malisa A; Lemnge M; Premji Z; Mwita A; Nkya W; Kataraihya J; Abdulla S; Beck HP; Mshinda H
    Am J Trop Med Hyg; 2004 Dec; 71(6):696-702. PubMed ID: 15642957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel mutations in the antifolate drug resistance marker genes among Plasmodium vivax isolates exhibiting severe manifestations.
    Garg S; Saxena V; Lumb V; Pakalapati D; Boopathi PA; Subudhi AK; Chowdhury S; Kochar SK; Kochar DK; Sharma YD; Das A
    Exp Parasitol; 2012 Dec; 132(4):410-6. PubMed ID: 23043980
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distribution of Plasmodium vivax pvdhfr and pvdhps alleles and their association with sulfadoxine-pyrimethamine treatment outcomes in Indonesia.
    Asih PB; Marantina SS; Nababan R; Lobo NF; Rozi IE; Sumarto W; Dewi RM; Tuti S; Taufik AS; Mulyanto ; Sauerwein RW; Syafruddin D
    Malar J; 2015 Sep; 14():365. PubMed ID: 26395428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutations of pvdhfr and pvdhps genes in vivax endemic-malaria areas in Kota Marudu and Kalabakan, Sabah.
    Sastu UR; Abdullah NR; Norahmad NA; Saat MN; Muniandy PK; Jelip J; Tikuson M; Yusof N; Sidek HM
    Malar J; 2016 Feb; 15():63. PubMed ID: 26850038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiology of drug-resistant malaria in Republic of Congo: using molecular evidence for monitoring antimalarial drug resistance combined with assessment of antimalarial drug use.
    Nsimba B; Jafari-Guemouri S; Malonga DA; Mouata AM; Kiori J; Louya F; Yocka D; Malanda M; Durand R; Le Bras J
    Trop Med Int Health; 2005 Oct; 10(10):1030-7. PubMed ID: 16185238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular surveillance of drug-resistance associated mutations of Plasmodium falciparum in south-west Tanzania.
    Schönfeld M; Barreto Miranda I; Schunk M; Maduhu I; Maboko L; Hoelscher M; Berens-Riha N; Kitua A; Löscher T
    Malar J; 2007 Jan; 6():2. PubMed ID: 17224049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The implication of dihydrofolate reductase and dihydropteroate synthetase gene mutations in modification of Plasmodium falciparum characteristics.
    A-Elbasit IE; Alifrangis M; Khalil IF; Bygbjerg IC; Masuadi EM; Elbashir MI; Giha HA
    Malar J; 2007 Aug; 6():108. PubMed ID: 17686173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic Polymorphisms in Plasmodium vivax Dihydrofolate Reductase and Dihydropteroate Synthase in Isolates from the Philippines, Bangladesh, and Nepal.
    Thongdee P; Kuesap J; Rungsihirunrat K; Dumre SP; Espino E; Noedl H; Na-Bangchang K
    Korean J Parasitol; 2015 Apr; 53(2):227-32. PubMed ID: 25925184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sensitivity to antifolates and genetic analysis of Plasmodium vivax isolates from Thailand.
    Rungsihirunrat K; Na-Bangchang K; Hawkins VN; Mungthin M; Sibley CH
    Am J Trop Med Hyg; 2007 Jun; 76(6):1057-65. PubMed ID: 17556611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emergence of an unusual sulfadoxine-pyrimethamine resistance pattern and a novel K540N mutation in dihydropteroate synthetase in Plasmodium falciparum isolates obtained from Car Nicobar Island, India, after the 2004 Tsunami.
    Lumb V; Das MK; Mittra P; Ahmed A; Kumar M; Kaur P; Dash AP; Singh SS; Sharma YD
    J Infect Dis; 2009 Apr; 199(7):1064-73. PubMed ID: 19220141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular surveillance of mutations in dihydrofolate reductase and dihydropteroate synthase genes of Plasmodium falciparum in Ethiopia.
    Gebru-Woldearegai T; Hailu A; Grobusch MP; Kun JF
    Am J Trop Med Hyg; 2005 Dec; 73(6):1131-4. PubMed ID: 16354825
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High prevalence of Pfdhfr-Pfdhps quadruple mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from Bioko Island, Equatorial Guinea.
    Jiang T; Chen J; Fu H; Wu K; Yao Y; Eyi JUM; Matesa RA; Obono MMO; Du W; Tan H; Lin M; Li J
    Malar J; 2019 Mar; 18(1):101. PubMed ID: 30914041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymorphisms in Plasmodium falciparum dhfr and dhps genes and age related in vivo sulfadoxine-pyrimethamine resistance in malaria-infected patients from Nigeria.
    Happi CT; Gbotosho GO; Folarin OA; Akinboye DO; Yusuf BO; Ebong OO; Sowunmi A; Kyle DE; Milhous W; Wirth DF; Oduola AM
    Acta Trop; 2005 Sep; 95(3):183-93. PubMed ID: 16023986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic mutations in Plasmodium falciparum and Plasmodium vivax dihydrofolate reductase (DHFR) and dihydropteroate synthase (DHPS) in Vanuatu and Solomon Islands prior to the introduction of artemisinin combination therapy.
    Gresty KJ; Gray KA; Bobogare A; Wini L; Taleo G; Hii J; Cheng Q; Waters NC
    Malar J; 2014 Oct; 13():402. PubMed ID: 25311473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different allele prevalence in the dihydrofolate reductase and dihydropteroate synthase genes in Plasmodium vivax populations from China.
    Miao M; Yang Z; Cui L; Ahlum J; Huang Y; Cui L
    Am J Trop Med Hyg; 2010 Dec; 83(6):1206-11. PubMed ID: 21118923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.